Multiple sclerosis is a challenging disease process with new hope using disease modifying drugs. To learn more about the PASSAGE trial, visit www.passagestudy.com or download the attached flyer.
The Lafayette Clinical Research Group is dedicated to helping deliver high quality research and expert clinical care. Multiple sclerosis research is simply one area of focus we are currently seeking participants. To learn more about our practice and experience visit www.lafayetteclinicalresearch.com or call 765-269-7134.